Skip to main content
Jeffrey Gross, MD, Radiation Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

JeffreyGrossMDMS

Radiation Oncology New York, NY

Urologic Cancer

Assistant Attending, Memorial Sloan Kettering Cancer Center

Overview of Dr. Gross

Dr. Jeffrey Gross is a radiation oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from McGaw Medical Center of Northwestern University and has been in practice 7 years. He specializes in urologic cancer. He has more than 10 publications and over 150 citings.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Radiation Oncology, 2016 - 2020
  • Northwestern University
    Northwestern UniversityMS, Clinical Investigation, 2018
  • Ascension Illinois/Saint Francis
    Ascension Illinois/Saint FrancisInternship, Transitional Year, 2015 - 2016
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2015
  • The University of Mighican
    The University of MighicanB.S., Biopsychology and Cognitive Science, Philosophy, Honors, 2003 - 2007

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2020 - 2025
  • NJ State Medical License
    NJ State Medical License 2020 - 2025
  • IL State Medical License
    IL State Medical License 2015 - 2020
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Journal Articles

  • Radiotherapy Field Design and Lymphedema Risk Following Regional Nodal Irradiation for Breast Cancer  
    Jeffrey P. Gross, Sean Sachdev, Irene B. Helenowski, David Lipps, John P. Hayes, Eric D. Donnelly, Jonathan B. Strauss, Int J Radiat Oncol Biol Phys, 3/31/2018

Abstracts/Posters

  • Impact of expression of Nuclear Factor Kappa B in locally advanced cervical caner patients treated with definitive chemoradiation on treatment outcomes
    Tamer Refaat, Eric Donald Donnelly, Sean Sachdev, Prarthana Dalal, Vamsi Parimi, Ahmed Elgowily, Samar Elachy, Irene B. Helenowski, Jeffrey Gross, John Robert Lurain, ..., J Clin Oncol 33:5s, 2015 (suppl; abstr e16589)
  • Impact of pretreatment P53 gene mutation in locally advanced cervical cancer patients treated with definitive chemoradiation on treatment outcomes
    Prarthana Dalal, Tamer Refaat, Eric Donald Donnelly, Sean Sachdev, Vamsi Parimi, Samar Elachy, Ahmed Elgowily, Irene B. Helenowski, Jeffrey Gross, John Robert Lurain, ..., J Clin Oncol 33:5s, 2015 (suppl; abstr e16506)
  • EZH2 protein expression as a prognostic marker for tumor progression and brain metastasis in patients with lung adenocarcinoma
    Jeffrey Gross and Kirtee Reparia, Int J Radiat Oncol Biol Phys 90:5s, 2014 (suppl; abstr 204), 2014 Multidisciplinary Symposium in Thoracic Oncology, 10/30/2014
  • Join now to see all

Press Mentions

  • Study: Proton Therapy Better Than Radiation for Children's Brain Tumors
    Study: Proton Therapy Better Than Radiation for Children's Brain TumorsNovember 6th, 2018
  • Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
    Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive OutcomesNovember 5th, 2018

Hospital Affiliations